BBC StoryWorks: Turning the tide on non-alcoholic fatty liver disease
A MedTech Europe Documentary-style Short Film
Hear from a NAFLD patient and clinical experts about how the ELF Test has the ability to improve outcomes for patients and transform systems of care.
ELF Featured in the News
A Novel Two-step Pathway to Detect Liver Cirrhosis Earlier
Hear From the Expert:
The Two Step Pathway Using Non-invasive Tests
In this video, Dr. Ankur Srivastava, Consultant Gastroenterologist and Hepatologist at Southmead Hospital, North Bristol Trust, discusses his two-step primary care pathway approach of utilizing non-invasive tests to reduce unnecessary referrals and improve detection of severe disease in patients with NAFLD. This work was recently published in the Journal of Hepatology.
ELF Test identified as an important component of NAFLD clinical practice guidelines by the Chronic Liver Disease Foundation (CLDF)6
A small expert panel of hepatologists was tasked with creating straight-forward guidelines subsequent to the 2019 CLDF leadership forum. ELF plays a central role in the staging algorithm, and is the only proprietary serum fibrosis marker recommended by the expert panel.